Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia. (2014)

First Author: Giagounidis A
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 24706489

Publication URI:

Type: Journal Article/Review

Volume: 120

Parent Publication: Cancer

Issue: 12

ISSN: 0008-543X